| Literature DB >> 32094458 |
Erika Norén1, Christian Lindh2, Lars Rylander2, Anders Glynn3, Jonatan Axelsson2, Margareta Littorin2, Moosa Faniband2, Estelle Larsson2, Christel Nielsen2.
Abstract
Agricultural pesticides are extensively used for weed- and pest control, resulting in residues of these compounds in food. The general population is mainly exposed through dietary intake. Exposure to certain pesticides has been associated with adverse human health outcomes. Our aim was to assess urinary concentrations and temporal trends in the biomarkers of commonly used pesticides. Samples were collected from adolescents (n = 1060) in Scania, Sweden, from 2000 to 2017. Concentrations of 14 pesticide biomarkers were analyzed in urine using LC-MS/MS. Temporal trends in biomarker concentrations (ln-transformed) were evaluated using linear regression. Biomarkers of pyrethroids (3-PBA and DCCA), chlorpyrifos (TCPy), chlormequat (CCC), thiabendazole (OH-TBZ), and mancozeb (ETU) were detected in >90% of the population all sampling years. The biomarkers CCC and TCPy had the highest median concentrations (>0.8 µg/L), whereas the biomarkers of cyfluthrin (4F-3-PBA) and two pyrethroids (CFCA) had the lowest median concentrations (<0.02 µg/L). Increasing temporal trends were found for the biomarkers 3-PBA (3.7%/year), TCPy (1.7%/year) and biomarkers of pyrimethanil (11.9%/year) and tebuconazole (12.2%/year). Decreasing trends were found for CCC (-5.5%/year), OH-TBZ (-5.5%/year), and ETU (-3.9%/year). Our results suggest that Swedish adolescents are commonly exposed to pesticides in low concentrations (median concentrations <3.88 µg/L).Entities:
Keywords: Biomonitoring; Dietary exposure; Pesticides; Population based studies
Mesh:
Substances:
Year: 2020 PMID: 32094458 PMCID: PMC8075908 DOI: 10.1038/s41370-020-0212-8
Source DB: PubMed Journal: J Expo Sci Environ Epidemiol ISSN: 1559-0631 Impact factor: 5.563
Population characteristics.
| Age (years) | Sampling year | Median | P25–P75 | |
|---|---|---|---|---|
| 2000 | 271 (0) | 18 | 18–18 | |
| 2004 | 200 (0) | 18 | 18–18 | |
| 2009 | 314 (0) | 18 | 18–18 | |
| 2013 | 199 (5) | 18 | 18–18 | |
| 2017 | 195 (1) | 18 | 17–18 |
Nonparametric descriptive statistics of study participants, expressed per sampling year.
Pesticide compounds and corresponding exposure biomarkers.
| Pesticide category | Parent compound | Biomarker | Abbrev | LOD | QC mean | QC CV |
|---|---|---|---|---|---|---|
| Insecticide | Pyrethroidsa | 3-Phenoxybenzoic acid | 3-PBA | 0.009 | 20.5 | 10 |
| Cyfluthrin | 4-Fluoro-3-phenoxybenzoic acid | 4F-3-PBA | 0.005 | 20.9 | 6.0 | |
| Bifenthrin λ-cyhalothrin | 3-(-2-Chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylic acid | CFCA | 0.006 | 21.8 | 8.1 | |
| Permethrin cypermethrin cyfluthrin | 3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid | DCCA | 0.017 | 22.7 | 9.8 | |
| Chlorpyrifos | 3,5,6-Trichloro-2-pyridinol | TCPy | 0.063 | 23.5 | 4.9 | |
| Growth regulator | Chlormequat | Chlormequat | CCC | 0.010 | 31.3 | 4.7 |
| Mepiquat | Mepiquat | MQ | 0.011 | 8.40 | 5.1 | |
| Fungicide | Pyrimethanil | 4-Hydroxy-pyrimethanil | OH-PYM | 0.004 | 21.7 | 7.3 |
| Thiabendazole | 5-Hydroxy-thiabendazole | OH-TBZ | 0.002 | 21.1 | 3.9 | |
| Tebuconazole | Hydroxy tebuconazole | OH-TEB | 0.016 | 20.7 | 4.2 | |
| EBDCsb | Ethylene thiourea | ETU | 0.016 | 24.2 | 3.1 | |
| Propineb | Propylene thiourea | PTU | 0.1 | 21.3 | 22 | |
| Herbicide | 2,4-D | 2,4-Dichlorophenoxyacetic acid | 2,4-D | 0.108 | 22.2 | 6.8 |
| MCPA | 2-Methyl-4-dichlorophenoxyacetic acid | MCPA | 0.016 | 21.9 | 4.5 |
List of parent compounds and their corresponding biomarkers analyzed in urine. Calculated limit of detection (LOD) is listed in µg/L. Mean (µg/L) and coefficient of variance, CV (%), for quality control (QC) samples are listed for each compound.
aNonspecific biomarker of the pyrethroids permethrin, cypermethrin, deltamethrin, resmethrin, fenvalerate, phenothrin, cyphenothrin and lambda-cyhalothrin.
bNonspecific biomarker of several ethylene bis-dithiocarbamate (EBDC) fungicides but most commonly for mancozeb.
Descriptive statistics of urine concentrations.
| Compound | Year | % >LOD | Median | P25–P75 | P95 | Maximum | |
|---|---|---|---|---|---|---|---|
| 3-PBA | 2000 | 209 | 99 | 0.11 (0.08) | 0.06–0.22 (0.05–0.14) | 0.62 (0.43) | 5.64 (3.43) |
| 2004 | 197 | 96 | 0.10 (0.09) | 0.06–0.19 (0.05–0.16) | 0.56 (0.50) | 3.29 (2.66) | |
| 2009 | 254 | 100 | 0.15 (0.12) | 0.10–0.30 (0.08–0.24) | 1.02 (0.90) | 3.68 (2.79) | |
| 2013 | 294 | 100 | 0.15 (0.11) | 0.08–0.27 (0.06–0.20) | 0.79 (0.62) | 10.6 (7.89) | |
| 2017 | 195 | 100 | 0.21 (0.15) | 0.13–0.35 (0.11–0.30) | 0.92 (0.65) | 18.8 (15.2) | |
| 4F-3-PBA | 2000 | 209 | 63 | 0.01 (<LOD) | <LOD—0.01 (<LOD—0.01) | 0.03 (0.03) | 0.38 (0.21) |
| 2004 | 197 | 54 | 0.01 (<LOD) | <LOD—0.01 (<LOD—0.01) | 0.02 (0.02) | 0.05 (0.06) | |
| 2009 | 254 | 74 | 0.01 (<LOD) | <LOD—0.01 (<LOD—0.01) | 0.03 (0.03) | 0.25 (0.22) | |
| 2013 | 204 | 62 | 0.01 (<LOD) | <LOD—0.01 (<LOD—0.01) | 0.02 (0.02) | 0.29 (0.44) | |
| 2017 | 195 | 42 | <LOD (<LOD) | <LOD—0.01 (<LOD—0.01) | 0.06 (0.04) | 0.76 (0.54) | |
| CFCA | 2000 | 209 | 39 | <LOD (<LOD) | <LOD—0.01 (<LOD—0.01) | 0.05 (0.03) | 0.35 (0.18) |
| 2004 | 197 | 52 | 0.01 (0.01) | <LOD—0.01 (<LOD—0.01) | 0.03 (0.04) | 0.09 (0.11) | |
| 2009 | 254 | 76 | 0.01 (0.01) | <LOD—0.03 (<LOD—0.02) | 0.10 (0.07) | 1.72 (0.90) | |
| 2013 | 204 | 86 | 0.02 (0.02) | 0.01–0.04 (0.01–0.03) | 0.09 (0.07) | 0.38 (0.39) | |
| 2017 | 195 | 90 | 0.02 (0.02) | 0.01–0.05 (0.01–0.04) | 0.40 (0.31) | 1.76 (1.20) | |
| DCCA | 2000 | 209 | 97 | 0.18 (0.13) | 0.11–0.31 (0.08–0.21) | 0.78 (0.45) | 2.08 (3.09) |
| 2004 | 197 | 98 | 0.18 (0.18) | 0.12–0.30 (0.10–0.27) | 0.89 (0.86) | 8.28 (7.47) | |
| 2009 | 254 | 99 | 0.22 (0.16) | 0.12–0.34 (0.10–0.25) | 0.79 (0.60) | 5.35 (3.23) | |
| 2013 | 204 | 99 | 0.21 (0.15) | 0.13–0.31 (0.10–0.24) | 0.63 (0.49) | 3.53 (2.06) | |
| 2017 | 195 | 99 | 0.16 (0.13) | 0.11–0.25 (0.09–0.20) | 0.53 (0.41) | 0.91 (1.20) | |
| TCPy | 2000 | 209 | 99 | 0.82 (0.59) | 0.48–1.40 (0.38–0.96) | 3.50 (2.38) | 12.2 (7.39) |
| 2004 | 197 | 99 | 0.84 (0.80) | 0.53–1.60 (0.48–1.47) | 4.01 (3.69) | 13.9 (10.1) | |
| 2009 | 254 | 100 | 1.41 (1.08) | 0.85–2.37 (0.68–1.80) | 5.21 (3.99) | 19.6 (11.4) | |
| 2013 | 204 | 100 | 1.11 (0.86) | 0.64–2.16 (0.51–1.60) | 5.23 (5.06) | 43.0 (37.6) | |
| 2017 | 195 | 99 | 0.92 (0.70) | 0.52–1.74 (0.46–1.36) | 6.54 (5.19) | 30.1 (16.6) | |
| CCC | 2000 | 196 | 100 | 2.98 (2.01) | 1.21–8.71 (0.75–6.64) | 139 (66.1) | 272 (405) |
| 2004 | 197 | 100 | 2.30 (2.09) | 1.05–6.88 (6.94–15.5) | 16.4 (15.5) | 40.9 (40.3) | |
| 2009 | 254 | 100 | 3.88 (2.77) | 1.28–12.1 (0.89–10.4) | 41.5 (30.6) | 132 (132) | |
| 2013 | 204 | 100 | 1.29 (0.98) | 0.59–4.25 (0.41–3.80) | 17.1 (16.2) | 32.5 (25.1) | |
| 2017 | 196 | 100 | 1.17 (0.86) | 0.40–3.66 (0.31–3.18) | 16.8 (13.6) | 49.0 (35.8) | |
| MQ | 2000 | 196 | 87 | 0.26 (0.16) | 0.04–0.97 (0.03–0.73) | 3.80 (2.94) | 11.2 (16.6) |
| 2004 | 197 | 96 | 0.64 (0.52) | 0.13–2.11 (0.12–2.01) | 6.18 (6.40) | 14.0 (19.1) | |
| 2009 | 254 | 97 | 0.53 (0.33) | 0.10–1.56 (0.08–1.21) | 6.19 (5.10) | 47.3 (42.8) | |
| 2013 | 204 | 95 | 0.21 (0.17) | 0.07–0.83 (0.05–0.72) | 3.75 (3.02) | 64.1 (62.5) | |
| 2017 | 196 | 96 | 0.37 (0.31) | 0.08–1.83 (0.07–1.50) | 7.58 (6.02) | 58.3 (30.1) | |
| OH-TBZ | 2000 | 209 | 98 | 0.05 (0.03) | 0.02–0.17 (0.01–0.09) | 1.99 (1.91) | 17.4 (13.7) |
| 2004 | 197 | 95 | 0.02 (0.02) | 0.01–0.08 (0.01–0.08) | 0.92 (0.80) | 87.1 (53.7) | |
| 2009 | 254 | 97 | 0.01 (0.01) | 0.01–0.07 (0.00–0.06) | 1.60 (1.41) | 6.41 (5.20) | |
| 2013 | 204 | 92 | 0.02 (0.02) | 0.01–0.10 (0.00–0.09) | 1.83 (1.27) | 17.8 (21.1) | |
| 2017 | 195 | 94 | 0.01 (0.09) | 0.01–0.04 (0.00–0.03) | 0.40 (0.31) | 5.37 (4.51) | |
| OH-PYM | 2000 | 209 | 76 | 0.02 (0.01) | 0.01–0.07 (<LOD—0.05) | 0.42 (0.29) | 14.3 (8.67) |
| 2004 | 197 | 79 | 0.02 (0.02) | 0.01–0.07 (<LOD—0.07) | 0.96 (0.96) | 10.8 (6.84) | |
| 2009 | 254 | 88 | 0.03 (0.02) | 0.01–0.20 (0.00–0.15) | 1.47 (1.30) | 18.2 (22.9) | |
| 2013 | 204 | 93 | 0.05 (0.04) | 0.01–0.14 (0.01–0.11) | 1.63 (1.24) | 116 (98.2) | |
| 2017 | 195 | 99 | 0.09 (0.07) | 0.03–0.24 (0.03–0.21) | 18.0 (13.7) | 161 (136) | |
| OH-TEB | 2000 | 209 | 62 | 0.02 (0.01) | <LOD—0.04 (0.01–0.03) | 0.31 (0.22) | 1.98 (0.68) |
| 2004 | 197 | 76 | 0.04 (0.03) | 0.02–0.11 (0.02–0.09) | 0.78 (0.85) | 2.54 (2.39) | |
| 2009 | 254 | 93 | 0.08 (0.06) | 0.04–0.14 (0.03–0.10) | 0.38 (0.34) | 20.5 (12.0) | |
| 2013 | 204 | 93 | 0.09 (0.08) | 0.05–0.17 (0.04–0.14) | 0.90 (0.71) | 6.87 (3.66) | |
| 2017 | 195 | 94 | 0.12 (0.09) | 0.05–0.27 (0.04–0.22) | 1.03 (0.86) | 12.4 (14.7) | |
| ETU | 2000 | 149 | 99 | 0.29 (0.22) | 0.14–0.64 (0.10–0.45) | 1.68 (1.10) | 4.58 (4.40) |
| 2004 | 196 | 99 | 0.40 (0.38) | 0.22–0.77 (0.19–0.76) | 3.03 (2.87) | 5.89 (7–26) | |
| 2009 | 254 | 99 | 0.34 (0.26) | 0.16–0.68 (0.13–0.52) | 2.02 (1.54) | 20.0 (8.84) | |
| 2013 | 204 | 97 | 0.25 (0.22) | 0.12–0.69 (0.09–0.46) | 1.60 (1.26) | 3.02 (5.23) | |
| 2017 | 196 | 98 | 0.18 (0.15) | 0.08–0.39 (0.06–0.34) | 1.19 (1.02) | 7.30 (6.80) | |
| 2,4-D | 2000 | 209 | 65 | 0.12 (<LOD) | <LOD—0.20 (<LOD—0.14) | 0.69 (0.48) | 2.26 (2.14) |
| 2004 | 197 | 58 | 0.12 (0.11) | <LOD—0.21 (<LOD—0.20) | 0.44 (0.40) | 0.95 (0.82) | |
| 2009 | 254 | 58 | <LOD (<LOD) | <LOD—0.15 (<LOD—0.11) | 0.35 (0.24) | 2.05 (2.13) | |
| 2013 | 204 | 69 | 0.13 (0.10) | <LOD—0.22 (<LOD—0.17) | 0.43 (0.43) | 2.24 (0.39) | |
| 2017 | 195 | 39 | <LOD (<LOD) | <LOD—0.14 (<LOD—0.11) | 0.37 (0.29) | 1.64 (1.28) | |
| MCPA | 2000 | 209 | 72 | 0.03 (0.02) | <LOD—0.05 (<LOD—0.03) | 0.12 (0.11) | 1.06 (0.56) |
| 2004 | 197 | 73 | 0.03 (0.03) | 0.02–0.05 (0.02–0.05) | 0.17 (0.14) | 0.90 (0.75) | |
| 2009 | 254 | 69 | 0.02 (0.02) | <LOD—0.04 (<LOD—0.03) | 0.14 (0.11) | 0.41 (0.40) | |
| 2013 | 204 | 66 | 0.02 (0.02) | <LOD—0.05 (<LOD—0.04) | 0.16 (0.13) | 0.63 (0.67) | |
| 2017 | 195 | 55 | 0.02 (0.01) | <LOD—0.03 (<LOD—0.02) | 0.10 (0.07) | 1.78 (1.22) |
Nonparametric estimates of density-adjusted concentrations in urine samples (µg/L). Creatinine adjusted concentrations are presented in brackets (µg/g creatinine). Detection frequency is reported as percent above limit of detection.
Fig. 1Urinary concentrations of pesticide biomarkers.
Density-adjusted concentrations in urine (log-scale) for metabolites: a 3-PBA, b DCCA, c TCPy, d CCC, e MQ, f OH-TBZ, g OH-PYM, h OH-TEB, and i ETU in Swedish adolescents in Scania plotted against sampling year.
Analysis of temporal trends through linear regression.
| All samples | ||||
|---|---|---|---|---|
| Biomarker | 95 CI (%) | |||
| 3-PBA | 3.7 | 2.6, 4.7 | <0.01 | 0.05 |
| DCCA | –0.1 | –1.0, –0.8 | 0.802 | 0.00 |
| TCPy | 1.7 | 0.8, 2.6 | <0.01 | 0.01 |
| CCC | –5.5 | –7.0, –4.1 | <0.01 | 0.05 |
| MQ | 1.9 | –0.2, 4.1 | 0.06 | 0.00 |
| OH-TBZ | –5.5 | –7.3, –3.6 | <0.01 | 0.03 |
| OH-PYM | 11.9 | 9.3, 14.4 | <0.01 | 0.08 |
| OH-TEB | 12.2 | 10.5, 14.5 | <0.01 | 0.18 |
| ETU | –3.9 | –5.1, –2.7 | <0.01 | 0.04 |
Annual change (β, % per year) in concentrations (ln-transformed) of pesticide biomarkers in urine from Swedish adolescents in Scania, 2000–2017, for all samples.